Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-12-18

FDA Approved: PIRFENIDONE CAPSULE, 267 MG — Original Application (Macleods Pharmaceuticals Limited)

View source ↗

Summary

FDA approved an original ANDA for pirfenidone capsule 267 mg by Macleods Pharmaceuticals Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PIRFENIDONE CAPSULE, 267 MG (pirfenidone)

Snippet

ORIG AP for PIRFENIDONE CAPSULE, 267 MG (PIRFENIDONE CAPSULE, 267 MG)